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Anne O’Garra
Cytokines are dominant factors in driving the
development of T helper cell subsets via specific
signaling pathways. Transcription factors specific to the
T helper cell lineages have also been shown to
determine the commitment of Th1 and Th2 cells to the
production of distinct profiles of cytokines.
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The immune system is designed to eradicate a large variety
of invading pathogens with minimum immunopathology.
T helper cells, also known as CD4+ T cells, may be subdi-
vided into the T helper 1 (Th1) and the T helper 2 (Th2)
subsets, which produce distinct profiles of cytokines [1,2].
These Th1 and Th2 cells have opposing roles, regulating
immune responses to intracellular and extracellular
pathogens, respectively [1,2]. Th1 cells produce interferon-g
(IFN-g), interleukin-2 (IL-2) and tumor necrosis factor b
(TNF-b), and give rise to a cell-mediated immune response
protective against intracellular pathogens and viruses, but
these cells have also been implicated in organ-specific
autoimmune diseases (reviewed in [3]). Th2 cells produce
IL-4, IL-5 and IL-13 and activate mast cells and
eosinophils, thereby eradicating helminths and other extra-
cellular parasites, but in addition these cells are mediators of
allergic and atopic manifestations [2,4].
The differentiation program for these T helper cell subsets
can be influenced by a number of factors, including the
dose and form of antigen, the antigen-presenting cell and/or
costimulatory molecules; however, the dominant regulators
of T helper cell differentiation are undoubtedly cytokines
(reviewed in [3,5–7]). In addition to the expression of a dis-
tinct set of cytokine genes, the molecular basis for commit-
ment to a Th1 or Th2 phenotype can probably be
explained by a variety of mechanisms, including differential
cytokine signaling, exclusive cytokine receptor expression,
differential expression of transcription factors, and/or differ-
ential chromatin remodeling of Th1- and Th2-specific
genes [3,8–10]. Significant progress has been made in iden-
tifying the transcription factors that control the develop-
ment of Th2 cells (reviewed in [3,8,9,11]), but very little
was known about the molecular basis of Th1 differentiation
until recently. Szabo et al. [12] now report the isolation of
T-bet, a novel Th1-specific transcription factor that controls
the expression of the hallmark Th1 cytokine, IFN-g.
Remarkably, this group found that ectopic expression of
T-bet could not only induce endogenous IFN-g production
when introduced at an early stage into developing Th2
cells, but could also induce IFN-g production and repress
IL-4 and IL-5 production in otherwise committed Th2 cells.
Th1- and Th2-specific cytokines can augment the growth
or differentiation of their respective subset, and addition-
ally may inhibit the development of the opposing subset
(Figure 1). The development of Th1 cells from an anti-
genically naïve CD4+ T-cell precursor is driven by IL-12
produced by macrophages and dendritic cells [13]. Th1
commitment is enhanced by IFN-g, which upregulates the
IL-12 receptor while inhibiting the growth of Th2 cells
[3,5,9,13]. IL-12-induced activation of signal transducer
and activator of transcription 4 (Stat4) is critical for Th1
responses. Mice deficient in IL-12, the IL-12 receptor and
Stat4, or IFN-g, interferon regulatory factor 1 (IRF-1) and
IL-18 have markedly reduced Th1 responses (reviewed in
[9]). IL-18 has been shown to synergize with IL-12 for the
production of IFN-g by Th1 cells (reviewed in [3,14]) and,
furthermore, mice deficient in IL-18 or IL-12 show a
defect in Th1 responses to bacterial challenge [15]. On the
other hand, IL-4 induces Th2 development, via activation
of Stat6, and mice deficient in IL-4 or Stat6 have impaired
Th2 responses (reviewed in [3,5,9]). IL-4 also downregu-
lates IL-12 receptor expression on developing cells thereby
facilitating their commitment to the Th2 lineage (reviewed
in [3,5,9]). Thus, a specific genetic program results in the
differentiation towards either the Th1 or the Th2 lineage.
Significant progress has been made in identifying the tran-
scription factors that control the development of a naïve
CD4+ T-cell precursor into a Th2 cell. Two Th2-specific
transcription factors, c-Maf and GATA-3, have been
described [16–18]. c-Maf augments the induction of IL-4
by transactivation of the IL-4 promoter [16], and c-Maf-
deficient mice have impaired IL-4 production [19].
Ectopic expression of c-Maf, however, will not induce the
expression of IL-4 in developing Th1 cells. GATA-3 plays
a dominant role because it can induce a wide range of Th2-
specific cytokines in developing [17,20–22] and committed
[22] Th1 cells, and GATA-3 can also inhibit the production
of IFN-g [20–23]. These events do not occur via transcrip-
tional activation of the IL-4 promoter [22], but in part via
GATA-3-mediated downregulation of the b2 subunit of
the IL-12 receptor [20], and also via GATA-3-mediated
effects on chromatin remodeling of the IL-4 locus [22,23].
In contrast, very little is known about the molecular basis
of Th1 differentiation other than the required signaling
pathways discussed above. The Ets family member Erm,
which is induced by IL-12 in a Stat4-dependent manner,
is expressed specifically in Th1 cells, but does not affect
the production of Th1-specific cytokines [24]. The new
study by Szabo et al. [12] describes the isolation of a novel
protein belonging to the T-box family of transcription
factors, which have critical roles in diverse developmental
processes. Szabo et al. [12] have named their gene T-bet
(T-box expressed in T cells) as it is selectively expressed
in thymocytes and Th1 cells. T-bet was rapidly and selec-
tively induced in T-cell precursors driven down the Th1
but not the Th2 pathway. Cotransfection of the mouse
thymoma cell line EL4 with T-bet and a reporter gene
driven by the promoter region of the IFN-g gene resulted
in significant T-bet-specific transactivation of the reporter
gene in both stimulated and unstimulated cells. In con-
trast, T-bet expression repressed the activity of the IL-2
promoter, which correlates with previous observations
that, although Th1 cells express IL-2, these cells down-
regulate its expression as they differentiate. Interestingly,
T-bet had no effect on IL-4 promoter transactivation.
Populations of B220+ cells, which comprise B cells and
natural killer cells, upregulated T-bet upon culture with
IL-12, and this expression was further enhanced by IL-18.
Under conditions in which cells were stimulated by IL-12
and IL-18, significant levels of IFN-g production were
observed, compared with those observed in the presence
of either of the cytokines alone. This difference was
observed even though T-bet was induced by IL-12. It is
possible that IL-18 induces another factor required for
IFN-g production [25], or that T-bet has to be expressed
above a certain threshold to achieve significant induction
of IFN-g [12]. Indeed, dose-dependent effects on lineage
determination have been observed for other transcription
factors [26]. This proposal agrees with recent findings that,
although ectopic expression of the b2 subunit of the IL-12
receptor in developing Th2 cells results in the ability of
IL-12 to activate Stat4 and proliferation in these cells, it
does not lead to significant production of IFN-g [27].
Two main systems have been used for studying the factors
that drive Th1 and Th2 development. The first involves
polyclonal stimulation of T cells by, for example, trigger-
ing the T-cell receptor with antibodies against CD3
together with antibodies against the costimulator CD28.
The second involves deriving T cells from transgenic
mice expressing a specific T-cell receptor and stimulating
them with the antigen recognised by this receptor in the
context of antigen-presenting cells [3]. In such systems,
retroviral infection of primary CD4+ T cells with T-bet
resulted in a dramatic increase in the number of IFN-g-
producing cells as compared with cells not expressing
T-bet. Moreover, ectopic expression of T-bet in T cells
cultured under conditions that would drive them towards
a Th2 phenotype also gave rise to large numbers of IFN-g-
producing cells, in contrast to the controls. In addition,
introduction of T-bet into developing Th2 cells also led to
a marked reduction in the number of IL-4-producing cells,
and this decrease was independent of IFN-g signaling.
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Figure 1
IL-12 and IL-4 direct the development of Th1
and Th2 subsets producing IFN-g or IL-4, via
Stat4- and Stat6-dependent pathways,
respectively. Th2 cells express the
transcription factors c-Maf and GATA-3.
Ectopic expression of GATA-3 induces the
expression of Th2-specific cytokines and
inhibits IFN-g production in developing and
committed Th1 cells. T-bet, a newly described
Th1-specific T-box transcription factor
induces IFN-g and represses IL-4 and IL-5 in
both developing and committed Th2 cells.
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Reversibility of Th1 and Th2 populations is largely abro-
gated after one week in culture, although stable commit-
ment to a T helper phenotype occurs after three weeks of
stimulation under polarizing conditions [28]. Remarkably,
introduction of T-bet into such stably committed Th2
populations dramatically increased the numbers of IFN-
g-producing cells, and reduced the number of IL-4- and
IL-5-producing cells [12]. Thus T-bet can convert Th2
cells into Th1 cells. Ectopic expression of T-bet in a
homogeneous Th2 clone, however, only minimally
increased the number of IFN-g-producing cells. This mar-
ginal effect may be because the chromatin configuration at
the relevant loci is no longer accessible or because the
array of factors necessary for inducing IFN-g gene expres-
sion is no longer present. T-bet expression in the Th2
clone still resulted in a significant reduction of IL-4- and
IL-5-producing cells, however, showing that the ability of
T-bet to suppress Th2 development extends even to
long-term clones. T-bet therefore initiates Th1 genetic
programs while repressing the opposing Th2 programs.
The effect of T-bet in repressing the Th2 program while
simultaneously enhancing the Th1 program is reminiscent
of GATA-3, which indirectly represses IFN-g expression
[20,21,23], while simultaneously inducing Th2 differentia-
tion [17,18,20–23]. Furthermore, it has recently been shown
that GATA-3 will induce the production of IL-4 and IL-5
in committed Th1 cells [22], and that it induces a Th2-spe-
cific DNase I hypersensitive site in the IL-4 locus in com-
mitted Th1 cells. The level of IL-4 induction by GATA-3
in committed Th1 cells is lower than in developing Th1
cells, similar to the reduced effect of T-bet on induction of
IFN-g in the Th2 clone. This induction of IL-4 and IL-5 by
GATA-3 is significantly enhanced by addition of cyclic
AMP. Thus, the balance of T-bet or GATA-3 ultimately
determines whether a developing T helper cell becomes a
Th1 or Th2 cell, respectively, even though other factors are
undoubtedly involved in fine-tuning this regulation.
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